SCHEMBL27375459

SCHEMBL27375459

NCc1cc(F)cc(-c2ccco2)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 4/20 0.59
PRMT6 Q96LA8 1/20 0.43
ERN1 O75460 1/20 0.40
KAT6A Q92794 2/20 0.40
GRM5 P41594 1/20 0.38
PIK3R1 P27986 2/20 0.38
PIK3CA P42336 2/20 0.38
CLK4 Q9HAZ1 1/20 0.38
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
POLB P06746 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HTR2C P28335 1/20 0.37
PTPN1 P18031 1/20 0.36
TOP1 P11387 1/20 0.36
PTGS1 P23219 1/20 0.35
FLT3 P36888 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31456962 1.00 TAAR1 (0.59) TAAR1PRMT6ERN1KAT6AGRM5
SCHEMBL18876483 0.82 ERN1 (0.49) TAAR1PRMT6ERN1KAT6AGRM5
SCHEMBL109478 0.77 TAAR1 (0.70) TAAR1PRMT6ALDH1A1POLBHTR2C
SCHEMBL28217068 0.77 TAAR1 (0.58) TAAR1PRMT6MEN1NPC1ALDH1A1
Hydrochloric Acid SCHEMBL1014846 0.76 TAAR1 (0.68) TAAR1PRMT6ALDH1A1POLBHTR2C
SCHEMBL112138 0.74 TAAR1 (1.00) TAAR1PRMT6HTR2C
SCHEMBL24459423 0.73 TAAR1 (0.58) TAAR1
SCHEMBL18311308 0.71 KAT6A (0.55) TAAR1ERN1KAT6APTPN1
SCHEMBL19662062 0.71 TAAR1 (0.58) TAAR1PRMT6ERN1PIK3R1PIK3CA
SCHEMBL30557741 0.71 PIK3R1 (0.54) TAAR1PRMT6ERN1PIK3R1PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024030000-A1 NOVEL COMPOUND AS HYPOXIA-INDUCIBLE FACTOR 1(HIF-1) INHIBITOR OR VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) INHIBITOR, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 넥스트젠바이오사이언스 2024-02-08 WO disclosed